Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cells
about
Human epididymis protein-4 (HE-4): a novel cross-class protease inhibitorHelicobacter pylori infection, but not low-dose aspirin, results in a local reduction of the secretory leukocyte protease inhibitor in gastroduodenal mucosaComprehensive analysis of HE4 expression in normal and malignant human tissues.Construction of a metastasis-associated gene subtracted cDNA library of human colorectal carcinoma by suppression subtraction hybridization.Secretory leukocyte protease inhibitor antagonizes paclitaxel in ovarian cancer cellsWAP four-disulfide core domain protein 2 promotes metastasis of human ovarian cancer by regulation of metastasis-associated genesIncreased secretory leukocyte protease inhibitor (SLPI) production by highly metastatic mouse breast cancer cells.Domain landscapes of somatic mutations in cancer.Progranulin is a potential prognostic biomarker in advanced epithelial ovarian cancers.Paracrine SLPI secretion upregulates MMP-9 transcription and secretion in ovarian cancer cellsSerum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer managementChemoresistant colorectal cancer cells and cancer stem cells mediate growth and survival of bystander cellsBlood-based lung cancer biomarkers identified through proteomic discovery in cancer tissues, cell lines and conditioned mediumThe secretory leukocyte protease inhibitor (SLPI) suppresses cancer cell invasion but promotes blood-borne metastasis via an invasion-independent pathway.Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters.Gene expression profiling of human ovarian tumours.Fish oil alters tamoxifen-modulated expression of mRNAs that encode genes related to differentiation, proliferation, metastasis, and immune response in rat mammary tumors.HE4 (WFDC2) Promotes Tumor Growth in Endometrial Cancer Cell LinesTumor immunoediting and immunosculpting pathways to cancer progression.CD24 cell surface expression in Mvt1 mammary cancer cells serves as a biomarker for sensitivity to anti-IGF1R therapy.Overexpression of protease inhibitor-dead secretory leukocyte protease inhibitor causes more aggressive ovarian cancer in vitro and in vivo.Secretory leukocyte peptidase inhibitor and lung cancer.High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer.Utility of progranulin and serum leukocyte protease inhibitor as diagnostic and prognostic biomarkers in ovarian cancer.HE4 transcription- and splice variants-specific expression in endometrial cancer and correlation with patient survival.In-depth LC-MS/MS analysis of the chicken ovarian cancer proteome reveals conserved and novel differentially regulated proteins in humansSecretory leukocyte protease inhibitor is a survival and proliferation factor for castration-resistant prostate cancer.Anti-tumor effect of SLPI on mammary but not colon tumor growth.Evolving role of serum biomarkers in the management of ovarian cancer.Secretory leukocyte protease inhibitor is a proliferation and survival factor for pancreatic cancer cells.Imbalance of Clara cell-mediated homeostatic inflammation is involved in lung metastasis.Down-regulation of secretory leukocyte protease inhibitor expression in gastric mucosa is a general phenomenon in Helicobacter pylori-related gastroduodenal diseases.Secretory leukocyte protease inhibitor (SLPI) as a potential target for inhibiting metastasis of triple-negative breast cancers.Prognostic significance of HE4 expression in pulmonary adenocarcinoma.Effect of secretory leukocyte protease inhibitor on migration and invasion of human KB oral carcinoma cells
P2860
Q24303274-660B7E91-82FB-4735-8BAA-BB9A94594EB3Q28194601-FAA3FB18-ABA1-43CF-B5D5-53F748D6041EQ30440200-42F9FC16-89CC-4A0A-AF92-664211D23FC0Q31052792-3784671E-C1FF-4B2A-8420-BFD0BD1114BAQ33596742-D3EF4B03-51F1-4EEB-A7B7-8B77ABD8DE5DQ33876850-AB450644-0406-4CEE-9C93-D78F7DC2C5BCQ34027580-13F57751-2027-42B6-9AED-94F532D17FC6Q34324973-991F23F8-AB9B-4350-82C6-D6C899BC66F3Q34384802-E839DD15-CCD5-4860-89DE-40FA250FB258Q35154168-C6327015-851C-4A1E-846F-A12E71244A93Q35612779-BF6AA69F-E2F3-49A1-B197-077CA15C7F86Q35623336-6FDFA8C2-F8B9-4176-9877-01A15BF79145Q35957217-359A839F-7EA6-4795-AA56-6BDBC1C37EADQ36190618-D9FEAECE-5D5D-4F95-9D47-E0A39AB3E27FQ36607592-3B6F90B8-E54A-4093-B0B5-131E932F280BQ36612374-4AE1ED7B-187E-4B24-AB45-69E5A2F5CD51Q36677374-50334762-768B-4F9C-B393-033E93B6FCE8Q36790307-7CDA0058-EB8C-4037-83C7-A0436D4307A1Q36896195-8829486E-44D2-4A50-A64A-B5852F0E3542Q36903909-5C03CDCD-EE99-481E-978D-8EA0508543CFQ37114356-A4715647-C457-42F3-B9DF-6116E0BE2C1AQ37124951-4EAD22E7-8364-477B-88C1-F2CF7DFC413EQ37228483-CBDA5625-6D75-44D9-A15B-42ADDAF4BCA7Q37340571-9B5844A7-5CFF-4522-8996-7AE9BF674614Q37375504-5784EC0E-B714-4FBD-9896-C71AE028B78AQ37607036-1B3A5C0A-E4B2-406B-B514-40119FE37C4CQ38794223-C661B1A8-2D19-4218-A763-FDC7FDB63182Q39318982-AFDC9E6F-C23A-41B4-BD83-9FA5FDEDF18FQ40361610-BC7893E9-6396-485A-AC32-7F2114B99FABQ42183510-EBF56B32-8357-4DB8-98F5-56C241EFDBEDQ42746157-06301B10-3052-4503-BB9B-06DB1E2D93F1Q44359066-6C804D71-F13E-45A7-94E2-58EE4724EDB9Q47220626-AF00F747-F46C-45BE-94F6-F9F2C3312520Q51747947-85AD0574-DA95-4553-A12E-6B4B8064A0A4Q58287182-B0B9FE4B-687D-49FB-8FCB-A77373DD533C
P2860
Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cells
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Secretory leukocyte protease i ...... atic potential of cancer cells
@ast
Secretory leukocyte protease i ...... atic potential of cancer cells
@en
type
label
Secretory leukocyte protease i ...... atic potential of cancer cells
@ast
Secretory leukocyte protease i ...... atic potential of cancer cells
@en
prefLabel
Secretory leukocyte protease i ...... atic potential of cancer cells
@ast
Secretory leukocyte protease i ...... atic potential of cancer cells
@en
P2093
P2860
P356
P1476
Secretory leukocyte protease i ...... atic potential of cancer cells
@en
P2093
Gholamreza Hassanzadeh Ghassabeh
Hilde Revets
Jing Zhang
Nick Devoogdt
P2860
P304
P356
10.1073/PNAS.1037154100
P407
P577
2003-05-05T00:00:00Z